FDA approves Idhifa to treat relapsed acute myeloid leukemia
The U.S. Food and Drug Administration today approved a new drug, Idhifa, to treat adults with relapsed or refractory acute myeloid leukemia.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Food and Drug Administration (FDA) | Health | Leukemia